Tanigawa H, Kosazuma T, Tanaka H, Obori R
J Toxicol Sci. 1978 Feb;3(1):69-86. doi: 10.2131/jts.3.69.
M73101 was given orally to pregnant mice (0, 100, 400 and 800 mg/kg/day) and rats (0, 100, 300 and 600mg/kg/day) during the major organogenesis to assess the influences of prenatal and postnatal development of progeny. There were no apparent effects of M73101 on litter size, fetal mortality or sex ratio in both species, although slight decrease in body weight occurred in fetuses of mice and rats exposed to the largest dose. No external, internal or skeletal malformations attributable to M73101 were observed in mouse and rat fetuses. No apparent influences of M73101 on postnatal development of mouse or rat offspring were seen.
在主要器官形成期,给怀孕小鼠(剂量为0、100、400和800毫克/千克/天)和大鼠(剂量为0、100、300和600毫克/千克/天)口服M73101,以评估其对后代产前和产后发育的影响。在这两个物种中,M73101对产仔数、胎儿死亡率或性别比例均无明显影响,尽管暴露于最大剂量的小鼠和大鼠胎儿体重略有下降。在小鼠和大鼠胎儿中未观察到归因于M73101的外部、内部或骨骼畸形。未发现M73101对小鼠或大鼠后代的产后发育有明显影响。